NEW YORK (GenomeWeb News) — Ariadne Genomics said today that it has partnered with the University of Oklahoma to develop a cancer-related pathways collection.
The collection will then become available to Ariadne customers as an add-on to its pathway-analysis product line, according to the company.
The University of Oklahoma has already deployed Ariadne’s Pathway Studio software tool to develop a collection of cancer-related pathways.